National drug shortages worsen during COVID-19 crisis: Proposal for a comprehensive model to monitor and address critical drug shortages

Am J Health Syst Pharm. 2020 Oct 14;77(21):1778-1785. doi: 10.1093/ajhp/zxaa228.

Abstract

In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.

Keywords: coronavirus; COVID-19; drug shortage; drug therapy; hospital; medication systems; pharmacy service.

MeSH terms

  • COVID-19*
  • Drug Industry / organization & administration*
  • Humans
  • Models, Organizational
  • Pharmaceutical Preparations / supply & distribution*
  • United States

Substances

  • Pharmaceutical Preparations